CAS offers open-access chemical database for COVID-19
The Chemical Abstracts Service (CAS), a division of the American Chemical Society, announced it has released an open-access database of chemical compounds with known or potential antiviral properties to assist organizations with COVID‑19 research.
GE BioPharma sale to Danaher is complete
The divestment of GE's BioPharma business unit to Danaher is complete, according to an announcement by both companies on March 31.
Viscient to bioprint lung tissues to accelerate COVID-19 research
Biotherapeutics company Viscient Biosciences said it, or a sister company to be funded and launched shortly using the same technology, will use 3D bioprinting technology to create lung tissue to support viral infectivity research and search for an effective therapy against SARS-CoV-2, the novel coronavirus which causes COVID-19.
Bruker launches plethora of new products online
Bruker is showcasing a number of its new analytical systems and other products for biopharma and forensics applications. The products include a new gas analyzer as well as a benchtop x-ray elemental analyzer.
Kleo, Green Cross collaborate on COVID-19 NK combination therapy
Kleo Pharmaceuticals is joining forces with Green Cross LabCell of South Korea to advance testing of natural killer (NK) cell therapies as a potential treatment for COVID-19 patients.
Agilent unveils new handheld raw material ID system
Agilent Technologies has launched Vaya Raman, a handheld raw material identity verification system for pharmaceutical manufacturers.
Generation Bio, Vir partner for mAbs against COVID-9
Generation Bio and Vir Biotechnology have agreed to collaborate on research into the use of monoclonal antibodies against the SARS-CoV-2 virus that causes COVID-19.
J&J seeks to release COVID-19 vaccine by 2021
Johnson & Johnson has selected a lead COVID-19 vaccine candidate from a number of options it has been working on since January. The company hopes to release a vaccine by 2021.
Charles River, Deciphex form digital pathology partnership
Charles River Laboratories has entered into a partnership with software firm Deciphex to offer a digital pathology workflow platform.
LabShares Newton offers free space for COVID-19 research
LabShares Newton is offering free, fully equipped biosafety level 2 lab space, facilities, and resources for researchers addressing the global COVID-19 pandemic, it announced on March 30.